| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Morphological Sciences (M.B., T.G.-C., R.G., A.V.-B., A.B.), Physiology (M.L., R.S., C.D.), and Medicine (F.C.), School of MedicineUniversity Clinical Hospital, University of Santiago de Compostela, E-15782 Santiago de Compostela, Spain; and Centre National de la Recherche Scientifique UMR 5578 (G.M.), Université Claude Bernard-Lyon 1, Villeurbane, France
Address correspondence and requests for reprints to: Prof. Tomás García-Caballero, Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela, San Francisco, E-15782 Santiago de Compostela, Spain. E-mail: cmhisihq{at}usc.es
Orexins-A and -B are hypothalamic peptides derived from a precursor called prepro-orexin and relationated with the stimulation of food intake. They act on G protein receptors named orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R), respectively. In the present study, we used RT-PCR and immunohistochemical techniques to detect the presence of OX1R and OX2R in human pituitary. A band of the expected size for both OX1R and OX2R was shown in human pituitary by RT-PCR. The cellular localization of OX1R and OX2R was carried out using histological techniques. By consecutive sections we demonstrated that OX1R was present in acidophil, diffusely distributed cells, which represent the half of the total adenohypophysis cell population. As was expected, these cells were shown to coexpress GH. OX2R was found in the pars intermedia and in clusters of basophil cells of the anterior pituitary, which coexpress ACTH. These results were confirmed by double immunofluorescence techniques. We also found focal positivity in axon terminals of neurohypophysis, more intense for OX2R than for OX1R. In conclusion, these results demonstrated for the first time that OX1R and OX2R were expressed by somatotrope and corticotrope cells, respectively.
This article has been cited by other articles:
![]() |
E. Goncz, M. Z. Strowski, C. Grotzinger, K. W. Nowak, P. Kaczmarek, M. Sassek, S. Mergler, B. F. El-Zayat, M. Theodoropoulou, G. K. Stalla, et al. Orexin-A Inhibits Glucagon Secretion and Gene Expression through a Foxo1-Dependent Pathway Endocrinology, April 1, 2008; 149(4): 1618 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor Endocrinology, October 1, 2006; 147(10): 4977 - 4984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Winsky-Sommerer, A. Yamanaka, S. Diano, E. Borok, A. J. Roberts, T. Sakurai, T. S. Kilduff, T. L. Horvath, and L. de Lecea Interaction between the Corticotropin-Releasing Factor System and Hypocretins (Orexins): A Novel Circuit Mediating Stress Response J. Neurosci., December 15, 2004; 24(50): 11439 - 11448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Caminos, R. Nogueiras, M. Blanco, L. M. Seoane, S. Bravo, C. V. Alvarez, T. Garcia-Caballero, F. F. Casanueva, and C. Dieguez Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland Endocrinology, November 1, 2003; 144(11): 5089 - 5097. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Small, M.-L. Goubillon, J. F. Murray, A. Siddiqui, S. E. Grimshaw, H. Young, V. Sivanesan, T. Kalamatianos, A. R. Kennedy, C. W. Coen, et al. Central Orexin A Has Site-Specific Effects on Luteinizing Hormone Release in Female Rats Endocrinology, July 1, 2003; 144(7): 3225 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, N. Bruggemann, A. Dendorfer, and P. Dominiak Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors Endocrinology, April 1, 2003; 144(4): 1219 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Overeem, S. W. Kok, G. J. Lammers, A. A. Vein, M. Frolich, A. E. Meinders, F. Roelfsema, and H. Pijl Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E641 - E647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Taylor and W. K. Samson The other side of the orexins: endocrine and metabolic actions Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E13 - E17. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, Q. Wang, M. Yan, M. Hernandez, C. Gong, W. C. Boon, Y. Murata, Y. Ueta, and C. Chen Orexin-A Augments Voltage-Gated Ca2+ Currents and Synergistically Increases Growth Hormone (GH) Secretion with GH-Releasing Hormone in Primary Cultured Ovine Somatotropes Endocrinology, December 1, 2002; 143(12): 4609 - 4619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kukkonen, T. Holmqvist, S. Ammoun, and K. E. O. Akerman Functions of the orexinergic/hypocretinergic system Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1567 - C1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Samson and M. M. Taylor Hypocretin/orexin suppresses corticotroph responsiveness in vitro Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1140 - R1145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |